Site Members can sign up for company wide alerts
Lawsuit Overview
Feb. 04, 2013 (Shareholders Foundation) -- An investor in shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) filed a lawsuit in effort to stop the proposed takeover of MAP Pharmaceuticals Inc by Allergan, Inc for $25.00 per NASDAQ:MAPP share. The plaintiff alleges that the defendants breached their fiduciary duties owed NASDAQ:MAPP stockholders by agreeing to sell the company too cheap...
You must register (for free) or login to view the entire case.